Skip to Main Content

Author Details

Gareth Rivalland
Auckland City Hospital
2010
21
8
PMIDPaper TitleJournal TitlePublished Year
36184068Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial.J Thorac Oncol2023
35099823Loss of STING expression is prognostic in non-small cell lung cancer.J Surg Oncol2022
35772118Current role of sentinel lymph node biopsy in early-stage melanoma.N Z Med J2022
34953676NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort.Clin Lung Cancer2022
35073733PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.Future Oncol2022
33416262Cardiac Troponin I and T in Checkpoint Inhibitor-associated Myositis and Myocarditis.J Immunother2021
33904520A case of hyperprolactinaemia in a patient with metastatic melanoma.Melanoma Res2021
32540558NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.Lung Cancer2020
34589929Osimertinib in NSCLC: Real-World Data From New Zealand.JTO Clin Res Rep2020
32676326Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.Transl Lung Cancer Res2020
31106127Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Transl Lung Cancer Res2019
31285867Standard dose osimertinib for erlotinib refractory T790M-negative <i>EGFR</i>-mutant non-small cell lung cancer with leptomeningeal disease.J Thorac Dis2019
30429008The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.Lung Cancer2018
30142389Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma.J Thorac Oncol2018
28267397Standard of care in immunotherapy trials: Challenges and considerations.Hum Vaccin Immunother2017
27283865Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.Lancet Oncol2016
30643561Combination approaches in NSCLC involving immune checkpoint inhibitors.Lung Cancer Manag2016
27753035Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.Adv Exp Med Biol2016
26453294Update on Mucin-1 immunotherapy in cancer: a clinical perspective.Expert Opin Biol Ther2015
24859241Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand.Pharmacoeconomics2014
20824998Pulmonary barotrauma and cerebral arterial gas embolism during hyperbaric oxygen therapy.Aviat Space Environ Med2010
  • 1 - 21 of 21

Recommended Authors

Malaka Ameratunga
Australia Central Clinical School, Monash University
Career Start Year 2014
Number of shared co-authors 8
Amy L Cummings
university of california los angeles School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Caroline E McCoach
UCSF Helen Diller Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
Career Start Year 2009
Number of shared co-authors 10
Saiama N Waqar
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Gideon M Blumenthal
Oncology Center of Excellence
Career Start Year 2008
Number of shared co-authors 0
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 0
Iacopo Petrini
University of Pisa
Career Start Year 2006
Number of shared co-authors 0
Arun Rajan
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 1
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Matthew A Gubens
University of California san francisco
Career Start Year 2003
Number of shared co-authors 0
Hussein A Tawbi
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Aaron Lisberg
Jonsson Comprehensive Cancer Center, university of california los angeles
Career Start Year 2002
Number of shared co-authors 1
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Fiona Blackhall
The University of Manchester
Career Start Year 2000
Number of shared co-authors 3
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Career Start Year 1999
Number of shared co-authors 1
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 2
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Richard W Joseph
Mayo Clinic Hospital
Career Start Year 1994
Number of shared co-authors 0
Jonathan W Goldman
David Geffen School of Medicine at university of california los angeles
Career Start Year 1991
Number of shared co-authors 2
Dean A Fennell
University of Leicester
Career Start Year 1990
Number of shared co-authors 2
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 3
Grant A McArthur
University of Melbourne
Career Start Year 1986
Number of shared co-authors 4
Roy S Herbst
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers 9
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 8
Bibhusal Thapa
Northern Hospital
Co-authored papers 3
Carmel Murone
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Prudence A Russell
St Vincent's Hospital
Co-authored papers 1
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 1
Simon J Mitchell
University of Auckland
Co-authored papers 1
Khashayer Asadi
Co-authored papers 1
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers 1
Simon Knight
Churchill Hospital
Co-authored papers 1
Khashayar Asadi
Austin Hospital
Co-authored papers 1
Dexiang Gao
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Gavin M Wright
St. Vincent's Hospital, University of Melbourne
Co-authored papers 1
Anthony T Papenfuss
Co-authored papers 1
Daniel L Cameron
The Walter and Eliza Hall Institute of Medical Research
Co-authored papers 1
Dirk Schadendorf
Co-authored papers 1
Georgina V Long
Co-authored papers 1
Adrienne Morey
The Canberra Hospital
Co-authored papers 1
Benjamin Solomon
Peter MacCallum Cancer Centre
Co-authored papers 1
Release 1.2